论文部分内容阅读
膀胱移行细胞癌(简称膀优癌)是泌尿系统常见的恶性肿瘤,术后易复发和进展。近年采用术后膀洗药物灌往以降低其复发率和进展率,但均有一定的局限性和并发症。我们分别采用术中三联疗法与术后BCG膀优灌注预防肿瘤复发,均取得一定疗效。报告如下。亚临床资料1.1一般资料1989
Bladder transitional cell carcinoma (referred to as bladder cancer) is a common malignant tumor of the urinary system, postoperative recurrence and progress. In recent years, the use of bladder irrigation medication after irrigation to reduce the recurrence rate and rate of progress, but have some limitations and complications. We were using intraoperative triple therapy and postoperative BCG bladder gifted perfusion to prevent tumor recurrence, have achieved some effect. The report is as follows. Subclinical data 1.1 General information 1989